|
1. GLP-1s and cancer: What to know Full story
2. 3 new drugs to watch: Optum Full story
3. CEOs and CFOs from Cleveland Clinic, Intermountain Health and Geisinger join 375+ speakers dissecting capital allocation, partnership models and market expansion at Becker's CEO + CFO Roundtable in November. Be in the room — reserve your complimentary spot here.
4. Eli Lilly oral GLP-1 cuts body weight by 10% Full story
5. Pharma merger forms $6B company Full story
6. 47% cut in premium labor spend: South Shore Health's path to staffing success here.
7. AbbVie to acquire depression drug for $1.2B Full story
8. Krystal Biotech halts cancer drug trial Full story
Becker's Learning Opportunities
9. AI without change management doesn't work. Learn how this health system drives adoption here.
10. Jefferson Health + Kaiser react to AMA burnout data. Watch now here.
11. Akron Children's saw 95% retention across 22 specialties with ambient AI. See how — here.
12. Interested in more? See Becker’s full lineup of
webinars
and
whitepapers.
|
.png)
.png)
